We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer's Xalatan Patent Upheld by Appeals Court
Pfizer's Xalatan Patent Upheld by Appeals Court
August 19, 2005
A federal appeals court has affirmed a 2004 district court ruling that Par Pharmaceutical’s generic version of Pfizer’s glaucoma drug Xalatan infringed on a Pfizer patent for the product.